1996
Lefkovits, J, Ivanhoe, RJ, Califf, RM, Bergelson, BA, Anderson, KM, Stoner, GL, Weisman, HF, and Topol, EJ
(1996).
Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigators
.
Lesnefsky, EJ, Lundergan, CF, Hodgson, JM, Nair, R, Reiner, JS, Greenhouse, SW, Califf, RM, and Ross, AM
(1996).
Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience
.
Liao, L, Jollis, JG, DeLong, ER, Peterson, ED, Morris, KG, and Mark, DB
(1996).
Impact of an interactive video on decision making of patients with ischemic heart disease
.
Liu, L, Krinsky, VI, Grant, AO, and Starmer, CF
(1996).
Cardiac transient outward potassium current: a pulse chemistry model of frequency-dependent properties
.
Mahaffey, KW, Granger, CB, Collins, R, O'Connor, CM, Ohman, EM, Bleich, SD, Col, JJ, and Califf, RM
(1996).
Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy
.
Mahanna, EP, Blumenthal, JA, White, WD, Croughwell, ND, Clancy, CP, Smith, LR, and Newman, MF
(1996).
Defining neuropsychological dysfunction after coronary artery bypass grafting
.
Mark, DB
(1996).
Implications of cost in treatment selection for patients with coronary heart disease
.
Mark, DB
(1996).
Treating myocardial infarction in the post-GUSTO era. A US perspective
.
Mark, DB
(1996).
Economics and Quality of Life After Acute Myocardial Infarction: Insights from GUSTO-I
.
Mark, DB, Talley, JD, Topol, EJ, Bowman, L, Lam, LC, Anderson, KM, Jollis, JG, Cleman, MW, Lee, KL, Aversano, T, Untereker, WJ, Davidson-Ray, L, and Califf, RM
(1996).
Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators
.
McConkie-Rosell, A, Wilson, C, Piccoli, DA, Boyle, J, DeClue, T, Kishnani, P, Shen, JJ, Boney, A, Brown, B, and Chen, YT
(1996).
Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease
.
Meinzer, FC, Fownes, JH, and Harrington, RA
(1996).
Growth indices and stomatal control of transpiration in Acacia koa stands planted at different densities
.
Midgette, AS, Griffith, JL, Califf, RM, Laks, MM, Dietz, SB, Beshansky, JR, and Selker, HP
(1996).
Prediction of the infarct-related artery in acute myocardial infarction by a scoring system using summary ST-segment and T- wave changes
.
Narins, CR, Hillegass, WB, Nelson, CL, Tcheng, JE, Harrington, RA, Phillips, HR, Stack, RS, and Califf, RM
(1996).
Relation between activated clotting time during angioplasty and abrupt closure
.
Newby, KH, Pisano, E, Krucoff, MW, Green, C, and Natale, A
(1996).
Incidence and clinical relevance of the occurrence of bundle- branch block in patients treated with thrombolytic therapy
.
Newby, LK and Califf, RM
(1996).
Identifying patient risk: the basis for rational discharge planning after acute myocardial infarction
.
Newby, LK, Califf, RM, Guerci, A, Weaver, WD, Col, J, Horgan, JH, Mark, DB, Stebbins, A, Van, de, Gore, JM, and Topol, EJ
(1996).
Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial
.
Newby, LK, Rutsch, WR, Califf, RM, Simoons, ML, Aylward, PE, Armstrong, PW, Woodlief, LH, Lee, KL, Topol, EJ, and Van, de
(1996).
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators
.
Newman, MF, Croughwell, ND, Blumenthal, JA, Lowry, E, White, WD, and Reves, JG
(1996).
Cardiopulmonary bypass and the central nervous system: potential for cerebral protection
.
O'Brien, JE, Peterson, ED, Keeler, GP, Berdan, LG, Ohman, EM, Faxon, DP, Jacobs, AK, Topol, EJ, and Califf, RM
(1996).
Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions
.
O'Connor, CM, Meese, RB, McNulty, S, Lucas, KD, Carney, RJ, LeBoeuf, RM, Maddox, W, Bethea, CF, Shadoff, N, Trahey, TF, Heinsimer, JA, Burks, JM, O'Donnell, G, Krucoff, MW, and Califf, RM
(1996).
A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II Investigators
.
Ohman, EM, Armstrong, PW, Christenson, RH, Granger, CB, Katus, HA, Hamm, CW, O'Hanesian, MA, Wagner, GS, Kleiman, NS, Harrell, FE, Califf, RM, and Topol, EJ
(1996).
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators
.
Onken, JE, Brazer, SR, Eisen, GM, Williams, DM, Bouras, EP, DeLong, ER, Long, TT, Pancotto, FS, Rhodes, DL, and Cotton, PB
(1996).
Predicting the presence of choledocholithiasis in patients with symptomatic cholelithiasis
.
Packer, M, O'Connor, CM, Ghali, JK, Pressler, ML, Carson, PE, Belkin, RN, Miller, AB, Neuberg, GW, Frid, D, Wertheimer, JH, Cropp, AB, and DeMets, DL
(1996).
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group
.
Pahlm, US, Pahlm, O, and Wagner, GS
(1996).
The standard 11-lead ECG. Neglect of lead aVR in the classical limb lead display
.